Onkos Surgical, a provider of musculoskeletal oncology and complex orthopaedic devices, has announced the completion of the 1,000th case utilising its personalised, 510(k) cleared My3D patient-specific pelvic implant platform.
The company says the milestone 'reflects the impact of innovative 3D printing technology and personalised approaches to orthopaedic cases' where anatomy, bone loss, tumour involvement, and revision history benefit from an individualised approach.
Through the My3D platform, Onkos Surgical combines collaborative case planning, advanced imaging, 3D anatomic modelling, and patient-specific implant design to support surgeons in planning and executing orthopaedic procedures. Onkos says the platform helps to reduce delivery times.
"Reaching the 1,000th personalised My3D pelvic implant case is a meaningful milestone for Onkos and for the surgeons who partner with us on solutions for their patients," said Onkos Founder and CEO, Patrick Treacy. "Our personalised approach is built around understanding each patient's unique anatomy and helping surgeons translate that understanding into a thoughtful reconstruction plan."
"Reaching 1,000 My3D Pelvis cases represents more than a milestone; it reflects the knowledge and expertise our engineers have developed through close collaboration with surgeons. The clinical insights gathered from each case continue to strengthen our personalised design process and support future surgeon-led planning sessions," added Onkos Surgical's Director of Patient Solutions, Rick Swanson.
"Pelvic and acetabular reconstruction is an ideal procedure to leverage cutting-edge digital planning and personalised implants," offered Jeff Barry, MD, Associate Professor of Orthopaedic Surgery, Director of the Adult Reconstruction Hip and Knee Fellowship, UCSF Department of Orthopaedic Surgery, San Francisco, CA. "Patient-specific implant solutions can provide surgeons with an important reconstructive option when treating cases where standard approaches may not provide an adequate treatment to address the patient's anatomy or reconstruction goals. This product is the future of acetabular revision surgery, available now."
This milestone builds on Onkos Surgical's broader personalised solutions portfolio, which is designed to help surgeons evaluate patient-specific options when planning reconstruction solutions for their patients.
